Kyowa Hakko Bio Co., Ltd., a wholly owned subsidiary of Kyowa Hakko Kirin, Co., Ltd. was the first company in the world to successfully produce and commercialize amino acids using fermentation methods. ‘Hakko’, in Japanese means fermentation, reflecting its key technology. Kyowa is guided by its corporate mission to improve the health and well-being of people worldwide.
Kyowa Hakko Bio offers manufacturers and formulators one of the industry's most extensive lines of over 50 amino acids and related compounds, including D-Amino acids and branched-chain amino acids, as well as nucleic acids, bio-products and fine chemicals. Kyowa Hakko also offers an array of branded ingredients including Cognizin® Citicoline, Lumistor® L-Hydroxyproline, Pantesin® Pantethine and Setria® Glutathione.
Kyowa Hakko U.S.A., Inc. is the North America sales office for Kyowa Hakko Bio Co., Ltd., and Kyowa Hakko Chemical Co., Ltd. As an international health ingredients manufacturer and a world leader in the development, manufacturing and marketing of nutraceuticals, pharmaceuticals and food products. Kyowa Hakko Bio is a pioneer in the development and application of fermentation technology, Kyowa Hakko Bio maintains an ongoing commitment to research, developing innovative new products and quality management.